NEENAH, Wis., Dec. 9, 2010 (GLOBE NEWSWIRE) -- Plexus Corp. (Nasdaq:PLXS) announced today that it has entered into an agreement to purchase land for the construction of a new manufacturing facility in the Xiamen Xiangyu Free Trade Zone, adjacent to its current facility. This new facility will operate under the existing management team and will add approximately 180,000 square feet of manufacturing capacity. Construction is expected to begin in March 2011 with production to commence in the second half of calendar 2012. In addition, Plexus' current Xiamen, China manufacturing facility has received State Food and Drug Administration, P.R. China (SFDA) certification to support customers in the Medical industries. This certification allows Plexus to manufacture finished Class I and II medical devices for our customers that sell into China end-markets.
Plexus Announces Expansion And SFDA Certification In Xiamen, China
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.